Your name

English  |  Russian
Quick order About Mercator Portfolio Customers speak out
Please, Call back!
/Medical Chart: STADA CIS, Mexiprim

Medical Chart: STADA CIS, Mexiprim

7 October 2011 year

New material from the series of videos on STADA CIS Holding medications. This time the centre of attention is the brain and nerve cells… and they regenerate all the same!

Awards NewYorkFestival 2012

Finalist Certificate: Craft: Graphics
Finalist Certificate: Craft: Graphics

Our production team:

Design — Artur Prokurov, Dmitry Anashkin
3D Graphics — Artur Prokurov, Dmitry Anashkin
Music, 2D Animation — Dmitry Misharin
Director of Production — Stanislav Onishchenko
Project Managers — Кaterina Miroshnikova, Maria Chemezova

* Pursuant to provisions of the Federal Law dated 22 June 1998 No. 86-FZ «On Pharmaceuticals», the website only quotes the exact texts of monographs, research articles, reports presented at congresses, conferences and symposia meant for health and pharmaceutical professionals, as well as LLC Stada Marketing CIS product labels. Pursuant to the applicable legislation of the Russian Federation, this information can only be used by health and pharmaceutical professionals.
No part of this information can be regarded as a recommendation for a citizen (patient) to diagnose or treat any diseases or replace a consultation with a health professional. No part of this information can be interpreted as an appeal for a citizen (patient) to independently acquire or use any of the said pharmaceuticals. This information cannot be used by a citizen (patient) to independently make a decision concerning the medical application of any of the said pharmaceuticals and/or a decision to change the procedure of the medical application of any of the said pharmaceuticals recommended by a health professional.
This information pertains only to the pharmaceuticals registered in the Russian Federation in accordance with the procedure established by law. The names of the said pharmaceuticals registered in other countries, as well as recommendations concerning their medical application can be different from the information presented in this section of the website. Not all of the said pharmaceuticals that are in circulation in the Russian Federation are approved for medical use in other countries.


<iframe src='' width='586' height='329' frameborder='0' scrolling='auto' ></iframe>

Home | Site map | | NEWS | About Mercator | Experience | Contact information